-
公开(公告)号:US20250011304A1
公开(公告)日:2025-01-09
申请号:US18709091
申请日:2022-12-02
Applicant: Array BioPharma Inc.
Inventor: Connor James COWDREY
IPC: C07D403/12 , A61K9/20 , A61K31/4184 , A61K31/517 , A61K45/06
Abstract: This invention relates to a crystalline form of N-(2-chloro-3-((5-chloro-3-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)amino)-4-fluorophenyl)-3-fluoroazetidine-1-sulfonamide, pharmaceutical compositions comprising said crystalline form, and methods of using said crystalline form in the treatment of BRAF-associated diseases and disorders, such as BRAF-associated tumors.